En Carta Diagnostics
PrivateLast Round
Seed
Jul 10, 2026
Est. Valuation
$33M
Total Funding Raised
$7.34M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
En Carta Diagnostics is a biotechnology company that develops rapid point-of-care molecular diagnostic kits with an initial focus on the early diagnosis of Lyme disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
En Carta Diagnostics Comparables
Compare En Carta Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anavasi Diagnostics | 79% | |
| ExGen Dx | 77% | |
| Visby Medical | 71% | |
En Carta Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2026 | ||||
| Pre Seed | May 22, 2024 |
En Carta Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paris Biotech Santé | Pre Seed |
| 50 Partners | Pre Seed, Seed |
| Blue Forest Ventures | Seed |
| CentraleSupélec Venture | Seed, Pre Seed |
| Ring Capital | Seed |
| Bpifrance | Seed |
| PC'up Incubator | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 59% MoM, from 1.9K to 3K.
- Jul 10, 2026
$5.7M round led by Blue Forest Ventures
En Carta Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about En Carta Diagnostics's valuation, stock price, and market status.